Novartis India has enclosed intimation dated November 23, 2023 received from Link lntime India, Registrar and Transfer Agent, providing information regarding issue of duplicate share certificates in favour of shareholders of the Company. Further, in accordance with the SEBI Notification No. SEBI/LAD-NRO/GN/2022/66 dated January 24, 2022, read with SEBI Circular No. SEBI/HO/MIRSD/MIRSD_RTAMB/P/CIR/2022/8 dated January 25, 2022, letter of confirmation in lieu of the physical share certificates will be issued to the said shareholders of the Company within the prescribed timelines.
The above information is a part of company’s filings submitted to BSE.